Literature DB >> 7664174

Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis.

A K Ghosh1, S Dasgupta, A C Ghose.   

Abstract

Antileishmanial antibody responses in the sera of Indian kala-azar (KA) and post-KA dermal leishmaniasis (PKADL) patients were analyzed by enzyme-linked immunosorbent assay (ELISA) and immunoblot experiments using immunoglobulin G (IgG) class- and subclass-specific reagents. All sera showed antileishmanial reactivities in IgG ELISA which followed the order IgG1 > IgG2 > IgG3, with very little IgG4. Immunoblot analysis with IgG class-specific reagents revealed variable patterns of reactivity by KA and PKADL sera, although certain common bands around the 60- to 63-kDa regions were discernible. Sera from antimony-unresponsive KA cases, on the other hand, strongly recognized two bands at around 20 to 22 kDa, in addition to other bands in the high-molecular-mass region. Further analysis showed that the 28-kDa band was preferentially recognized by the IgG2 isotype, while 20- to 22-kDa and 60- to 63-kDa bands were recognized by the IgG1 isotype. Antibodies belonging to the IgG3 isotype reacted to antigens primarily in the region of 14 to 34 kDa and persisted in patients even several months after cure. Immunoblot studies also revealed the presence of a nonspecific band which arose as a result of binding between a 66-kDa leishmanial antigen and streptavidin. Finally, the results presented in this study suggest that certain leishmanial antigens preferentially stimulate the synthesis of a particular IgG subclass(es), depending on the nature of such antigens or their epitopes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664174      PMCID: PMC170148          DOI: 10.1128/cdli.2.3.291-296.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  37 in total

1.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  IgG4 antibodies in Egyptian patients with schistosomiasis.

Authors:  R Iskander; P K Das; R C Aalberse
Journal:  Int Arch Allergy Appl Immunol       Date:  1981

4.  Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis.

Authors:  B Veress; A Omer; A A Satir; A M El Hassan
Journal:  Immunology       Date:  1977-11       Impact factor: 7.397

5.  Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  J P Haldar; S Ghose; K C Saha; A C Ghose
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

6.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

7.  Surface antigenic change during differentiation of a parasitic protozoan, Leishmania mexicana: Identification by monoclonal antibodies.

Authors:  D Fong; K P Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  Serological investigations on Indian kala-azar.

Authors:  A C Ghose; J P Haldar; S C Pal; B P Mishra; K K Mishra
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

9.  Serological profiles in Indian post kala-azar dermal leishmaniasis.

Authors:  J P Haldar; K C Saha; A C Ghose
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

10.  Immunosuppression in Kenyan visceral leishmaniasis.

Authors:  M Ho; D K Koech; D W Iha; A D Bryceson
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

View more
  12 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages.

Authors:  Ziyan Yang; David M Mosser; Xia Zhang
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

3.  Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis.

Authors:  V L da Matta; S Hoshino-Shimizu; R Dietze; C E Corbett
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

4.  Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy.

Authors:  K Anam; F Afrin; D Banerjee; N Pramanik; S K Guha; R P Goswami; S K Saha; N Ali
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.

Authors:  Samiran Saha; Tuhina Mazumdar; Khairul Anam; Rajesh Ravindran; Bibhas Bairagi; Bibhuti Saha; Ramapada Goswami; Netai Pramanik; Subhashis K Guha; Sourjya Kar; Dwijadas Banerjee; Nahid Ali
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

6.  Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.

Authors:  Rajesh Ravindran; Khairul Anam; Bibhas C Bairagi; Bibhuti Saha; Netai Pramanik; Subhasis K Guha; Rama P Goswami; Dwijadas Banerjee; Nahid Ali
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

Review 7.  In vitro activity and in vivo efficacy of a combination therapy of diminazene and chloroquine against murine visceral leishmaniasis.

Authors:  Samuel W Mwololo; Joshua M Mutiso; John C Macharia; Alain J Bourdichon; Michael M Gicheru
Journal:  J Biomed Res       Date:  2015-03-04

8.  IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.

Authors:  Tapan Bhattacharyya; Armon Ayandeh; Andrew K Falconar; Shyam Sundar; Sayda El-Safi; Marissa A Gripenberg; Duncan E Bowes; Caroline Thunissen; Om Prakash Singh; Rajiv Kumar; Osman Ahmed; Osama Eisa; Alfarazdeg Saad; Sara Silva Pereira; Marleen Boelaert; Pascal Mertens; Michael A Miles
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

9.  Immunobiology of visceral leishmaniasis.

Authors:  Rajiv Kumar; Susanne Nylén
Journal:  Front Immunol       Date:  2012-08-14       Impact factor: 7.561

10.  Immune response regulation by leishmania secreted and nonsecreted antigens.

Authors:  Nuno Santarém; Ricardo Silvestre; Joana Tavares; Marta Silva; Sofia Cabral; Joana Maciel; Anabela Cordeiro-da-Silva
Journal:  J Biomed Biotechnol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.